Historically, infection prevention strategies in surgery have heavily focused on sterile operating rooms and antibiotic prophylaxis. However, a recent landmark study suggests that health professionals may have overlooked a crucial result determinant – the patient’s microbiome. This finding not only challenges the long-held principles established by Ignaz Semmelweis, known as the ‘hand-washing’ pioneer, but could potentially revolutionize strategies for preventing post-surgical infections.
In any surgical process, the opening of our skin barriers and the subsequent exposure of cell contents and blood vessels form a fertile playground for bacteria. Surgical site infections (SSIs) have been prevalent since the dawn of surgery itself. Semmelweis’s revolutionary approach directed our attention toward surgeon behavior and operating environment as potential sources of these infections, deemphasizing previously held beliefs attributing them to enigmatic environmental or social miasma.
Preoperative rituals, the development of sterile techniques, and advancements in antibiotics have substantially reduced SSIs over the years. However, despite significant scientific progress and economic incentives, the persistence of SSIs in ‘clean’ surgery – procedures that do not involve body cavities or organs harboring microbes – remains a challenge.
A noteworthy study conducted on 210 adult patients undergoing posterior spinal fusions, a type of clean surgery, proposes an intriguing theory. The research suggests that prophylaxis failures may not result from inadequate adherence to preoperative rituals, but rather the patient’s microbiome.
By using genomic signatures to identify various bacteria’s presence preoperatively, researchers found evidence that supports a link between the patient’s microbiome and SSIs. Nearly 86% of bacteria strains found on the patient’s skin before surgery bore similarity to those found in SSIs. About 59% of pathogens causing SSIs were resistant to antibiotics given at the time of surgery, indicating that antibiotic-resistant bacteria were already present on the patient’s skin prior to the surgery.
It appears that the preoperative genomic analysis may identify the most probable cause of SSIs for a specific patient while also detecting the presence of antimicrobial resistance. Thus, the cornerstone of Semmelweis’s belief – that the surgeon’s behavior is pivotal to SSIs – might not be entirely accurate. The patient’s microbiome could also be a significant contributor to SSIs.
If these findings prove consistent across other procedural cohorts, they could critically alter infection prevention strategies and provide a more personalized, patient-centered approach to healthcare. The prospect of personalizing surgical antibiotic prophylaxis according to each patient’s unique microbiome composition gives us a glimmer of hope in the escalating battle between broad-spectrum antibiotics and increasing population-level resistance.
The evolution of our understanding of SSIs, from Semmelweis’s hand-washing insights to modern genomic sequencing, validates the significance of the microbial composition and antibiotic resistance. An individualized approach to prophylactic strategies could massively transform surgical care and infection prevention.